Today: 15 June 2026
Vedanta hits fresh 52-week high near Rs 630 on demerger trade; broker targets stretch to Rs 686
7 January 2026
1 min read

Vedanta hits fresh 52-week high near Rs 630 on demerger trade; broker targets stretch to Rs 686

MUMBAI, January 7, 2026, 23:15 (IST)

  • Vedanta touched a 52-week high of 629.90 rupees and closed near flat at 622 rupees
  • Broker targets run from 625 to 686 rupees as the group pushes a five-way demerger plan
  • The stock’s RSI climbed to 78.6, a level traders often tag as “overbought”

Vedanta Ltd shares touched a 52-week high of 629.90 rupees on Wednesday before giving back most of the move, ending almost flat at 622 rupees. Business Today

The jump mattered because it came in a choppy session for Indian stocks, with investors scanning trade and geopolitical headlines ahead of the earnings season. “Markets remain sensitive to trade and geopolitical developments,” said Hitesh Tailor, a research analyst at Choice Equity Broking. Reuters

Brokerage targets have moved up as the rally has stretched into a month-long run. Kotak Securities has a target of 650 rupees, Investec has raised its target to 635 rupees, and Nuvama put fair value at 686 rupees, according to local media reports.

Much of that optimism hangs on Vedanta’s planned demerger — a carve-up into stand-alone listed businesses — which investors see as a way to put cleaner valuations on each unit. It also sets up a string of milestones in early 2026, including quarterly results and regulatory steps tied to the split.

Under the plan, the group would separate aluminium, oil and gas, iron and steel, and power into distinct listed entities, while the parent would keep its stake in Hindustan Zinc and “future-facing” businesses. Shareholders are set to receive equity shares in each of the four new entities in proportion to their existing holdings.

Emkay Global, which had a 625-rupee target on Vedanta, argued Hindustan Zinc’s exposure to silver was still not fully reflected in valuations. The brokerage estimated EBITDA — a measure of operating profit — at 258 billion rupees at spot prices versus 220 billion rupees in consensus forecasts, and said “silver exposure is underpriced”; Trendlyne data showed 13 analysts with a “buy” view on Vedanta. Goodreturns

Nuvama expects EBITDA to rise at a 16% compound annual growth rate (CAGR), or average yearly pace, over FY25-FY28, helped by lower aluminium cost of production and higher volumes. It also forecast consolidated net debt falling to 61,000 crore rupees by end-FY27, part of a broader deleveraging pitch that has stayed in focus for the group.

But the run has started to look stretched on the charts: Vedanta’s 14-day relative strength index (RSI), a momentum indicator, rose to 78.6, above the 70 level many traders treat as overbought. The demerger still needs other regulatory approvals, and Vedanta said a customs penalty and fine on its Balco unit would not have a material financial impact.

Stock Market Today

  • Soybeans Gain Despite Mixed Soymeal and Soy Oil Futures; Export Shipments Rise
    June 15, 2026, 3:58 PM EDT. Soybeans posted gains of 1 to 3 cents Monday, with the national average cash price reaching $10.63 per bushel. Soymeal and soy oil futures slipped lower amid wider commodity market pressures. Updated National Oilseed Processors Association (NOPA) data revealed soybean crushing in May at 208.785 million bushels, below expectations but up 8.27% year-over-year. Soybean oil stocks fell 10.9% month-over-month to 1.735 billion pounds. Export inspections for the week ending June 11 surged 26.8% from the prior week at 522,687 metric tons, led by shipments to Egypt, China, and Mexico, although year-to-date totals remain 19.5% below last year. Commodity traders liquidated soybean and soymeal positions sharply, signaling caution despite the recent market gains.

Latest articles

Regentis Biomaterials Jumps After Firm Scraps Public Offer

Regentis Biomaterials Jumps After Firm Scraps Public Offer

15 June 2026
RGNT soared up to 850% after Regentis withdrew its planned U.S. share offering, removing immediate dilution risk but leaving funding concerns unresolved as the company faces a $13.6 million annual loss, $7.4 million in cash, and a “going concern” warning; investors now await Q3 European GelrinC surgeon training as the next catalyst.
Fox Shares Slip After $22 Billion Roku Deal Sparks Debt, Dilution Fears

Fox Shares Slip After $22 Billion Roku Deal Sparks Debt, Dilution Fears

15 June 2026
Fox Class A shares plunged $10.90 to $54.95 after announcing a $22 billion cash-and-stock deal to buy Roku, as investors weighed the price, new debt, and share dilution; the next key catalyst is shareholder and regulatory approval, with Fox projecting the deal will boost free cash flow per share by the second full year after closing.
Mizuho Lifts D-Wave Quantum Target with QBTS Shares Higher, Still Cites Valuation Risks

Mizuho Lifts D-Wave Quantum Target with QBTS Shares Higher, Still Cites Valuation Risks

15 June 2026
D-Wave Quantum shares soared 14.3% to $26.71 after Mizuho raised its price target to $35 and maintained an Outperform rating, following the company’s first Analyst Day and expanded gate-model roadmap; despite $33.4 million in bookings and $588.4 million in cash, revenue fell 81% to $2.9 million and losses widened, making future execution critical ahead of the next earnings report.
UnitedHealth stock falls despite new price targets as Wall Street eyes Jan. 27 earnings
Previous Story

UnitedHealth stock falls despite new price targets as Wall Street eyes Jan. 27 earnings

Europa Clipper’s UV look at Comet 3I/ATLAS backs water-ice call as radio “technosignature” scan finds none
Next Story

Europa Clipper’s UV look at Comet 3I/ATLAS backs water-ice call as radio “technosignature” scan finds none

Go toTop